|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0306 | ED149545 | General Research Use | No | Male | White | 77 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0363 | ED148374 | General Research Use | No | Male | White | 57 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_0397 | ED149753 | General Research Use | No | Female | White | 74 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_2038 | ED149945 | General Research Use | No | Male | Black or African American | 64 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_3446 | ED149199 | General Research Use | No | Female | White | 84 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0851 | ED149241 | General Research Use | No | Male | White | 76 | 5 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1184 | ED149830 | General Research Use | No | Female | White | 81 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1719 | ED149715 | General Research Use | No | Female | White | 79 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2582 | ED149091 | General Research Use | No | Male | White | 67 | 5 - AREDS AMD Severity Scale Step 3 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_2602 | ED149960 | General Research Use | No | Female | White | 75 | 5 - AREDS AMD Severity Scale Step 5 | 10 - Central GA |
| AR2_3286 | ED148364 | General Research Use | No | Male | White | 83 | 5 - AREDS AMD Severity Scale Step | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_4097 | ED148083 | General Research Use | No | Male | White | 70 | 5 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_0815 | ED148038 | General Research Use | No | Female | White | 76 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1609 | ED149921 | General Research Use | No | Male | White | 85 | 5 - AREDS AMD Severity Scale Step 4 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1814 | ED148699 | General Research Use | No | Male | White | 77 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_2111 | ED149864 | General Research Use | No | Male | White | 73 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_3565 | ED148816 | General Research Use | No | Female | White | 61 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_3734 | ED148790 | General Research Use | No | Female | White | 74 | 5 - AREDS AMD Severity Scale Step 4 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_0928 | ED148959 | General Research Use | No | Female | White | 64 | 5 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_2338 | ED148031 | General Research Use | No | Male | White | 58 | 5 - AREDS AMD Severity Scale Step 4 | 4 - AREDS AMD Severity Scale Step 4 |